Varenicline tartrate is a partial agonist of α4/β2 nicotinic Acetylcholine receptors (nAChR) and a full agonist of a7 nAChR, it is also an effective activator of α3/β4 receptors with apparent EC50 in the mM range. Based on these characteristics, especially the partial agonistic activity towards the α4/β2 nAChR, it may be suitable for treating nicotine addiction.
产品描述
A Partial Agonist of alpha4/beta2 nAChR
产品形式
Varenicline tartrate is a partial agonist of α4/β2 nicotinic Acetylcholine receptors (nAChR) and a full agonist of a7 nAChR, it is also an effective activator of α3/β4 receptors with apparent EC50 in the mM range. Based on these characteristics, especially the partial agonistic activity towards the α4/β2 nAChR, it may be suitable for treating nicotine addiction.